162 related articles for article (PubMed ID: 35864062)
1. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
[TBL] [Abstract][Full Text] [Related]
3. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
[TBL] [Abstract][Full Text] [Related]
4. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Absar S; Nahar K; Kwon YM; Ahsan F
Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
[TBL] [Abstract][Full Text] [Related]
5. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
6. In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.
Hua X; Zhou L; Liu P; He Y; Tan K; Chen Q; Gao Y; Gao Y
J Thromb Thrombolysis; 2014 Jul; 38(1):57-64. PubMed ID: 24671732
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
8. Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis.
Absar S; Kwon YM; Ahsan F
J Control Release; 2014 Mar; 177():42-50. PubMed ID: 24417965
[TBL] [Abstract][Full Text] [Related]
9. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
[TBL] [Abstract][Full Text] [Related]
10. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
11. Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates.
Sundell IB; Marzec UM; Kelly AB; Chronos NA; Petersen LC; Hanson SR; Hedner U; Harker LA
Circulation; 1997 Aug; 96(3):941-8. PubMed ID: 9264505
[TBL] [Abstract][Full Text] [Related]
12. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
[TBL] [Abstract][Full Text] [Related]
13. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Maksimenko AV; Tischenko EG
J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
[TBL] [Abstract][Full Text] [Related]
14. Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis.
Li HD; Li R; Kong Y; Zhang W; Qi C; Wang D; Hao H; Liu Q
Front Immunol; 2022; 13():801727. PubMed ID: 35720286
[TBL] [Abstract][Full Text] [Related]
15. Laser thrombolysis and in vitro release kinetics of tPA encapsulated in chitosan polysulfate-coated nanoliposome.
Ahmaditabar P; Mahmoodi M; Taheri RA; Asefnejad A
Carbohydr Polym; 2023 Jan; 299():120225. PubMed ID: 36876826
[TBL] [Abstract][Full Text] [Related]
16. Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.
Matsuno H; Kozawa O; Niwa M; Ito T; Tanabe K; Nishida M; Hayashi H; Uematsu T
J Cardiovasc Pharmacol; 1998 Aug; 32(2):191-7. PubMed ID: 9700979
[TBL] [Abstract][Full Text] [Related]
17. Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease.
Quan X; Liang X; Ding Y; Han Y; Li J; Yuan M; Li Y; Yuan Z; Wang R; Zhao Y
ACS Nano; 2023 Apr; 17(7):6519-6533. PubMed ID: 36971410
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
McCarthy JR; Sazonova IY; Erdem SS; Hara T; Thompson BD; Patel P; Botnaru I; Lin CP; Reed GL; Weissleder R; Jaffer FA
Nanomedicine (Lond); 2012 Jul; 7(7):1017-28. PubMed ID: 22348271
[TBL] [Abstract][Full Text] [Related]
20. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
